AURKB and acute myeloid leukemia: To further elucidate the potential molecular mechanisms by which the DAV regimen results in cells overcoming the resistance caused by AURKB activation, we overexpressed AURKB in two AML cell lines (U937 and THP1) and analyzed their gene expression by RNA‐seq.